Aakaar Medical Technologies (NSE:AAKAAR) Retained Earnings: ₹155.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AAKAAR Aakaar Medical Technologies Ltd NSE:AAKAAR
21 GF Score
Price ₹58.40
! 3 Warning Signs
View Full Analysis

What is Aakaar Medical Technologies Retained Earnings?

Aakaar Medical Technologies NSE:AAKAAR +4.94% 21 Retained Earnings is ₹155.8 Mil as of Mar. 2026. GuruFocus rates NSE:AAKAAR with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Aakaar Medical Technologies's retained earnings for the quarter that ended in Mar. 2026 was ₹155.8 Mil.

Aakaar Medical Technologies's quarterly retained earnings declined from Mar. 2025 (₹89.5 Mil) to Sep. 2025 (₹0.0 Mil) but then increased from Sep. 2025 (₹0.0 Mil) to Mar. 2026 (₹155.8 Mil).

Aakaar Medical Technologies's annual retained earnings declined from Mar. 2024 (₹118.3 Mil) to Mar. 2025 (₹89.5 Mil) but then increased from Mar. 2025 (₹89.5 Mil) to Mar. 2026 (₹155.8 Mil).


Aakaar Medical Technologies  (NSE:AAKAAR) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Aakaar Medical Technologies Retained Earnings Historical Data

* Premium members only.

The historical data trend for Aakaar Medical Technologies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aakaar Medical Technologies Retained Earnings Chart

Aakaar Medical Technologies Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Retained Earnings
73.27 89.55 118.26 89.46 155.84

Aakaar Medical Technologies Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Retained Earnings Get a 7-Day Free Trial 118.26 0.00 89.46 0.00 155.84
NSE:AAKAAR
21GF Score
Aakaar Medical Technologies Ltd NSE:AAKAAR
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aakaar Medical Technologies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of ₹155.8 Mil mean?
Aakaar Medical Technologies (NSE:AAKAAR) has a Retained Earnings of ₹155.8 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Aakaar Medical Technologies and its competitors.
Is Aakaar Medical Technologies' Retained Earnings too high?
Aakaar Medical Technologies' current Retained Earnings is ₹155.8 Mil. Overall, Aakaar Medical Technologies has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' Retained Earnings compare to ABT and SYK?
Aakaar Medical Technologies' Retained Earnings of ₹155.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Aakaar Medical Technologies and its competitors. Aakaar Medical Technologies's current Retained Earnings is ₹155.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current Retained Earnings of ₹155.8 Mil. The current Retained Earnings is ₹155.8 Mil. Aakaar Medical Technologies' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current Retained Earnings is ₹155.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aakaar Medical Technologies Business Description

Address Telli Galli Cross Road, A - 801, Heritage Plaza, Andheri East, Mumbai, MH, IND, 400 069
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
21GF Score

Get the complete analysis for NSE:AAKAAR

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹58.40
Price